Loxo,Bayer gets U.S approval for cancer drug Larotrectinib Medical Dialogues Bureau28 Nov 2018 3:36 AMNew Delhi: A Loxo Oncology Inc drug larotrectinib shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation...
Loxo-Bayer cancer drug gets priority review from FDA Ruby Khatun Khatun1 Jun 2018 4:00 AMLoxo Oncology and Bayer AG said the U.S. Food and Drug Administration granted priority review to their cancer drug and would decide on the marketing...
